{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:52:16Z","timestamp":1789995136698,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Positively charged cyclodextrins (PCCDs) are molecular carriers of particular interest for their ability to readily enter into cancer cells. Of main interest, guanidino- and aminoalkyl- PCCDs can be conveniently synthesized and form stable and strong inclusion complexes with various active molecules bearing phosphate groups. We have addressed here the challenge to deliver into cancer cells phosphorylated gemcitabine drugs well known for their instability and inability to permeate cell membranes. NMR data corroborated by semiempirical theoretical calculations have shown that aminoalkyl-CDs form sufficiently stable complexes with both mono- and tri-phosphate forms of gemcitabine by simple mixing of the compounds in aqueous solution at physiological pH. Confocal microscopy and radioactivity counting experiments revealed that the developed systems enabled phosphorylated gemcitabine to penetrate efficiently into aggressive human breast cancer cells (MCF7), eventually leading to a substantial reduction of IC<jats:sub>50<\/jats:sub> values. Moreover, compared to free drugs, phosphorylated metabolites of gemcitabine encapsulated in PCCDs displayed improved <jats:italic>in vitro<\/jats:italic> activities also on the aggressive human cancer cells CCRF-CEM Ara-C\/8\u2009C, a nucleoside transport-deficient T leukemia cell line. The current study offers the proof-of-principle that phosphorylated nucleoside drugs could be efficiently transported by PCCDs into cancer cells.<\/jats:p>","DOI":"10.1038\/s41598-017-08727-y","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T10:15:54Z","timestamp":1502360154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells"],"prefix":"10.1038","volume":"7","author":[{"given":"Violeta","family":"Rodriguez-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Maksimenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Salzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lampropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannis G.","family":"Lazarou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Agostoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7961-5443","authenticated-orcid":false,"given":"Patrick","family":"Couvreur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Gref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Yannakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"8727_CR1","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/j.bmcl.2005.03.046","volume":"15","author":"SM Ali","year":"2005","unstructured":"Ali, S. M. et al. Synthesis and biological evaluation of gemcitabine\u2013lipid conjugate (NEO6002). Bioorg. Med. Chem. Lett. \n                           15, 2571\u20132574 (2005).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"8727_CR2","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/jnci\/91.21.1876","volume":"91","author":"JR Mackey","year":"1999","unstructured":"Mackey, J. R. et al. Gemcitabine Transport in Xenopus Oocytes Expressing Recombinant Plasma Membrane Mammalian Nucleoside Transporters. J. Natl. Cancer Inst. \n                           91, 1876\u20131881 (1999).","journal-title":"J. Natl. Cancer Inst."},{"key":"8727_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1593\/neo.81686","volume":"11","author":"S R\u00e9jiba","year":"2009","unstructured":"R\u00e9jiba, S., Bigand, C., Parmentier, C. & Hajri, A. Gemcitabine-Based Chemogene Therapy for Pancreatic Cancer Using Ad-dCK::UMK GDEPT and TS\/RR siRNA Strategies. Neoplasia \n                           11, 637\u2013650 (2009).","journal-title":"Neoplasia"},{"key":"8727_CR4","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/0006-2952(93)90444-2","volume":"45","author":"DY Bouffard","year":"1993","unstructured":"Bouffard, D. Y., Lalibert\u00e9, J. & Momparler, R. L. Kinetic studies on 2\u2032,2\u2032-difluorodeoxycytidine (gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase. Biochem. Pharmacol. \n                           45, 1857\u20131861 (1993).","journal-title":"Biochem. Pharmacol."},{"key":"8727_CR5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1124\/mol.104.006098","volume":"67","author":"CH Hsu","year":"2005","unstructured":"Hsu, C. H., Liou, J. Y., Dutschman, G. E. & Cheng, Y. C. Phosphorylation of Cytidine, Deoxycytidine, and Their Analog Monophosphates by Human UMP\/CMP Kinase Is Differentially Regulated by ATP and Magnesium. Molec. Pharmacol. \n                           67, 806\u2013814 (2005).","journal-title":"Molec. Pharmacol."},{"key":"8727_CR6","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1021\/jm00110a019","volume":"34","author":"CH Baker","year":"1991","unstructured":"Baker, C. H. et al. 2\u2032-Deoxy-2\u2032-methylenecytidine and 2\u2032-Deoxy-2\u2032,2\u2032-difluorocytidine 5\u2032-Diphosphates: Potent Mechanism-Based Inhibitors of Ribonucleotide Reductase. J. Med. Chem. \n                           34, 1879\u20131884 (1991).","journal-title":"J. Med. Chem."},{"key":"8727_CR7","first-page":"4453","volume":"56","author":"V Gandhi","year":"1996","unstructured":"Gandhi, V., Legha, J., Chen, F., Hertel, L. W. & Plunkett, W. Excision of 2\u2032,2\u2032- Difluorodeoxycytidine (Gemcitabine) Monophosphate Residues from DNA. Cancer Res. \n                           56, 4453\u20134459 (1996).","journal-title":"Cancer Res."},{"key":"8727_CR8","first-page":"4024","volume":"48","author":"V Heinemann","year":"1988","unstructured":"Heinemann, V., Hertel, L. W., Grindey, G. B. & Plunkett, W. Comparison of the Cellular Pharmacokinetics and Toxicity of 2\u2032,2\u2032-Difluorodeoxycytidine and 1-\u03b2-D-Arabinofuranosylcytosine. Cancer Res. \n                           48, 4024\u20134031 (1988).","journal-title":"Cancer Res."},{"key":"8727_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3109\/1061186X.2015.1073294","volume":"23","author":"V Rodriguez-Ruiz","year":"2015","unstructured":"Rodriguez-Ruiz, V. et al. Efficient \u201cgreen\u201d encapsulation of a highly hydrophilic anticancer drug in metal\u2013organic framework nanoparticles. J. Drug. Target. \n                           23, 759\u2013767 (2015).","journal-title":"J. Drug. Target."},{"key":"8727_CR10","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1016\/j.biomaterials.2013.01.063","volume":"34","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y., Kim, W. Y. & Huang, L. Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy. Biomaterials. \n                           34, 3447\u201358 (2013).","journal-title":"Biomaterials."},{"key":"8727_CR11","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/mt.2013.120","volume":"8","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC. Mol. Ther. \n                           8, 1559\u20131569 (2013).","journal-title":"Mol. Ther."},{"key":"8727_CR12","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1002\/chem.200701650","volume":"14","author":"N Mourtzis","year":"2008","unstructured":"Mourtzis, N., Paravatou, M., Mavridis, I. M., Roberts, M. L. & Yannakopoulou, K. Synthesis, characterization, and remarkable biological properties of cyclodextrins bearing guanidinoalkylamino and aminoalkylamino groups on their primary side. Chem. Eur. J. \n                           14, 4188\u20134200 (2008).","journal-title":"Chem. Eur. J."},{"key":"8727_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/mt.2011.284","volume":"20","author":"H Margus","year":"2012","unstructured":"Margus, H., Padari, K. & Pooga, M. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. Mol. Ther. \n                           20, 525\u2013533 (2012).","journal-title":"Mol. Ther."},{"key":"8727_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1039\/B614899A","volume":"5","author":"N Mourtzis","year":"2007","unstructured":"Mourtzis, N. et al. Per(6-guanidino-6-deoxy)cyclodextrins: synthesis, characterisation and binding behaviour toward selected small molecules and DNA. Org. Biomol. Chem. \n                           5, 125\u2013131 (2007).","journal-title":"Org. Biomol. Chem."},{"key":"8727_CR15","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/ejoc.200900040","volume":"14","author":"C Aggelidou","year":"2009","unstructured":"Aggelidou, C., Mavridis, I. M. & Yannakopoulou, K. Binding of nucleotides and nucleosides to per(6-guanidino-6-deoxy)-cyclodextrins in solution. Eur. J. Org. Chem. \n                           14, 2299\u20132305 (2009).","journal-title":"Eur. J. Org. Chem."},{"key":"8727_CR16","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.1021\/cr100242s","volume":"111","author":"AE Hargrove","year":"2011","unstructured":"Hargrove, A. E., Nieto, S., Zhang, T., Sessler, J. L. & Anslyn, E. V. Artificial receptors for the recognition of phosphorylated molecules. Chem. Rev. \n                           111, 6603\u20136782 (2011).","journal-title":"Chem. Rev."},{"key":"8727_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.urology.2006.03.069","volume":"68","author":"OC Farokhzad","year":"2006","unstructured":"Farokhzad, O. C. et al. Drug delivery systems in urology - getting \u201csmarter\u201d. Urology \n                           68, 463\u2013469 (2006).","journal-title":"Urology"},{"key":"8727_CR18","unstructured":"Gemcitabine triphosphate (dFdCTP) was kindly donated by the National Institute of Cancer, National Institute of Health, USA, http:\/\/dtp.nci.nih.gov."},{"key":"8727_CR19","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1021\/cr990045m","volume":"100","author":"K Burgess","year":"2000","unstructured":"Burgess, K. & Cook, D. Syntheses of nucleoside triphosphates. Chem. Rev. \n                           100, 2047\u20132060 (2000).","journal-title":"Chem. Rev."},{"key":"8727_CR20","unstructured":"Gerig, J. T. In On-line Textbook, Biophysical Society (http:\/\/www.biophysics.org\/img\/jtg2001-2.pdf) (2001)."},{"key":"8727_CR21","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1021\/ja00093a004","volume":"116","author":"AV Eliseev","year":"1994","unstructured":"Eliseev, A. V. & Schneider, H.-J. Molecular recognition of nucleotides, nucleosides and sugars by aminocyclodextrins. J. Am. Chem. Soc. \n                           116, 6081\u20136088 (1994).","journal-title":"J. Am. Chem. Soc."},{"key":"8727_CR22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1039\/a708602d","volume":"2","author":"P Schwint\u00e9","year":"1998","unstructured":"Schwint\u00e9, P., Darcy, R. & O\u2019Keeffe, F. Ditopic binding of nucleotides by heptakis(6-hydroxyethylamino-6-deoxy)-\u03b2-cyclodextrin. J. Chem. Soc., Perkin Trans. \n                           2, 805\u2013808 (1998).","journal-title":"J. Chem. Soc., Perkin Trans."},{"key":"8727_CR23","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1016\/j.tetlet.2007.03.096","volume":"48","author":"D-Q Yuan","year":"2007","unstructured":"Yuan, D.-Q. et al. Heptakis(6-deoxy-6-guanidino)-\u03b2-cyclodextrin: an artificial model for mitochondrial ADP\/ATP carrier. Tetrahedron Lett. \n                           48, 3479\u20133483 (2007).","journal-title":"Tetrahedron Lett."},{"key":"8727_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0020-1693(95)90050-G","volume":"235","author":"B Song","year":"1995","unstructured":"Song, B., Feldmann, G., Bastian, M., Lippert, B. & Sigel, H. Acid-base and metal ion-binding properties of 2\u2032-deoxycytidine-5\u2032-monophosphate (dCMP2\u2212) alone and coordinated to cis-diammine-platinum(II). Formation of mixed metal ion nucleotide complexes. Inorg. Chim. Acta \n                           235, 99\u2013109 (1995).","journal-title":"Inorg. Chim. Acta"},{"key":"8727_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/sj.leu.2403271","volume":"18","author":"M Pastor-Anglada","year":"2004","unstructured":"Pastor-Anglada, M. et al. Nucleoside transporters in chronic lymphocytic leukaemia. Leukemia \n                           18, 385\u201393 (2004).","journal-title":"Leukemia"},{"key":"8727_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-012-1667-x","volume":"19","author":"JJP Stewart","year":"2013","unstructured":"Stewart, J. J. P. Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters. J. Mol. Model. \n                           19, 1\u201332 (2013).","journal-title":"J. Mol. Model."},{"key":"8727_CR27","unstructured":"Stewart, J. J. P. MOPAC2012: Version 13.085. Stewart Computational Chemistry, Colorado Springs, CO, USA. http:\/\/openmopac.net (2013)."},{"key":"8727_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1039\/P29930000799","volume":"2","author":"A Klamt","year":"1993","unstructured":"Klamt, A. & Sch\u00fc\u00fcmann, G. COSMO: A new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient. J. Chem. Soc. Perkin Trans. \n                           2, 799\u2013805 (1993).","journal-title":"J. Chem. Soc. Perkin Trans."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08727-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08727-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08727-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:08:37Z","timestamp":1671786517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08727-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["8727"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-08727-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]},"assertion":[{"value":"19 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8353"}}